| Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study P Ueda, H Svanström, M Melbye, B Eliasson, AM Svensson, S Franzén, ... bmj 363, 2018 | 348 | 2018 |
| Plasma protein patterns as comprehensive indicators of health SA Williams, M Kivimaki, C Langenberg, AD Hingorani, JP Casas, ... Nature medicine 25 (12), 1851-1857, 2019 | 308 | 2019 |
| Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease P Ganz, B Heidecker, K Hveem, C Jonasson, S Kato, MR Segal, ... Jama 315 (23), 2532-2541, 2016 | 308 | 2016 |
| Validation of the GerdQ questionnaire for the diagnosis of gastro‐oesophageal reflux disease C Jonasson, B Wernersson, DAL Hoff, JG Hatlebakk Alimentary pharmacology & therapeutics 37 (5), 564-572, 2013 | 276 | 2013 |
| A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants S Halvorsen, W Ghanima, I Fride Tvete, C Hoxmark, P Falck, O Solli, ... European Heart Journal–Cardiovascular Pharmacotherapy 3 (1), 28-36, 2017 | 145 | 2017 |
| Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study B Pasternak, P Ueda, B Eliasson, AM Svensson, S Franzén, ... bmj 366, 2019 | 101 | 2019 |
| Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study OCW Rutherford, C Jonasson, W Ghanima, F Söderdahl, S Halvorsen European Heart Journal-Cardiovascular Pharmacotherapy 6 (2), 75-85, 2020 | 86 | 2020 |
| Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study B Pasternak, V Wintzell, M Melbye, B Eliasson, AM Svensson, S Franzén, ... bmj 369, 2020 | 80 | 2020 |
| Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden H Svanström, P Ueda, M Melbye, B Eliasson, AM Svensson, S Franzén, ... The lancet Diabetes & endocrinology 7 (2), 106-114, 2019 | 72 | 2019 |
| Randomised clinical trial: a comparison between a GerdQ‐based algorithm and an endoscopy‐based approach for the diagnosis and initial treatment of GERD C Jonasson, B Moum, C Bang, KR Andersen, JG Hatlebakk Alimentary pharmacology & therapeutics 35 (11), 1290-1300, 2012 | 71 | 2012 |
| Use of glucagon-like peptide 1 receptor agonists and risk of serious renal events: Scandinavian cohort study B Pasternak, V Wintzell, B Eliasson, AM Svensson, S Franzén, ... Diabetes Care 43 (6), 1326-1335, 2020 | 50 | 2020 |
| A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk SA Williams, R Ostroff, MA Hinterberg, J Coresh, CM Ballantyne, ... Science translational medicine 14 (639), eabj9625, 2022 | 44 | 2022 |
| Deciphering the plasma proteome of type 2 diabetes MA Elhadad, C Jonasson, C Huth, R Wilson, C Gieger, P Matias, ... Diabetes 69 (12), 2766-2778, 2020 | 41 | 2020 |
| Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation OCW Rutherford, C Jonasson, W Ghanima, F Söderdahl, S Halvorsen Heart 108 (5), 345-352, 2022 | 39 | 2022 |
| New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs OCW Rutherford, C Jonasson, W Ghanima, R Holst, S Halvorsen Open heart 5 (2), e000931, 2018 | 36 | 2018 |
| Aptamer-based proteomic platform identifies novel protein predictors of incident heart failure and echocardiographic traits M Nayor, MI Short, H Rasheed, H Lin, C Jonasson, Q Yang, K Hveem, ... Circulation: Heart Failure 13 (5), e006749, 2020 | 33 | 2020 |
| Plasma proteomics of renal function: a transethnic meta-analysis and Mendelian randomization study PR Matías-García, R Wilson, Q Guo, SB Zaghlool, JM Eales, X Xu, ... Journal of the American Society of Nephrology 32 (7), 1747-1763, 2021 | 25 | 2021 |
| Metabolic syndrome and the plasma proteome: from association to causation MA Elhadad, R Wilson, SB Zaghlool, C Huth, C Gieger, H Grallert, ... Cardiovascular diabetology 20 (1), 111, 2021 | 22 | 2021 |
| Glucagon-like peptide 1 receptor agonists and risk of diabetic retinopathy complications: cohort study in nationwide registers from two countries P Ueda, B Pasternak, B Eliasson, AM Svensson, S Franzén, ... Diabetes Care 42 (6), e92-e94, 2019 | 18 | 2019 |
| The comparative cardiovascular and renal effectiveness of sodium‐glucose co‐transporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: A Scandinavian cohort study P Ueda, V Wintzell, E Dahlqwist, B Eliasson, AM Svensson, S Franzén, ... Diabetes, Obesity and Metabolism 24 (3), 473-485, 2022 | 16 | 2022 |
